Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

NCT06708572 is registered in ClinicalTrials.gov with National Liver Institute, Egypt as lead sponsor.

NCT NCT06708572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06708572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
Lead sponsor
National Liver Institute, Egypt
Phase
Not applicable
Overall status
Recruiting
Start date
December 31, 2024
Completion date
October 30, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary atresia, granulocyte colony-stimulating factor